Cholesterol Metabolism Drug Efficacy Kidney Donation Risks Migraine Treatments PATH-HHT Study Epidemiology Lancet HIV Journal Survival Rates Beauty Parlour Stroke Syndrome Research Parental Intuition Burnout Studies Surgical Models Breast Cancer Mortality Science Translational Medicine
The phase IIa trial demonstrated rapid gastrointestinal symptom resolution alongside complete spike antigen clearance by day 21 in children treated with larazotide.